Skip to content
★ Sign in to follow
TS

Toor S.

Pharming Group N.V.
Total declarations
7
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€1.8M

Latest filing: trade of 15 Mar 2024 for Pharming Group N.V.. The register gives no publication date.

Filing timeline

BuySale
Toor S.

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

No signal scores available.

Toor S.: trading record in brief

All filings by Toor S. on record concern Pharming Group N.V. In total, 7 filings cover trades dated from 24 March 2022 to 15 March 2024.

On the market, this insider has only sold: 4 sales, €1.8M in total. Besides market trades, the filings include 1 option exercise.

The latest filing, published on 20 March 2024, reports a transaction in Pharming Group N.V. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from AFM disclosures alone and does not predict where the share price will go.

Companies and markets linked to Toor S.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ●
    Chief Operations OfficerExecutivesAFM delayPharming Group N.V.
    0AFM-MAR19
    187,700 sharesGewoon aandeelOTCISIN NL0010391025AFM:MAR19:20240315CA925C73-23E5-EE11-A314-005056BBFEB2
  • ▼
    Chief Commercial OfficerExecutivesAFM delayPharming Group N.V.
    €1.1M0AFM-MAR19
    1,000,000 shares@ €1.09Gewoon aandeelEURONEXT - EURONEXT AMSTERDAMISIN NL0010391025AFM:MAR19:20230815CC8EE2D7-D73C-EE11-A305-005056BB4E9F
  • ▼
    Chief Commercial OfficerExecutivesAFM delayPharming Group N.V.
    €113k0AFM-MAR19
    99,572 shares@ €1.13Gewoon aandeelEURONEXT - EURONEXT AMSTERDAMISIN NL0010391025AFM:MAR19:202308115B81394F-6A3B-EE11-A305-005056BB4E9F
  • ▼
    Chief Commercial OfficerExecutivesAFM delayPharming Group N.V.
    €348k0AFM-MAR19
    313,270 shares@ €1.11Gewoon aandeelEURONEXT - EURONEXT AMSTERDAMISIN NL0010391025AFM:MAR19:20230810282A1F08-6E3B-EE11-A30B-005056BBFEB2
  • ▼
    Chief Commercial OfficerExecutivesAFM delayPharming Group N.V.
    €272k0AFM-MAR19
    242,622 shares@ €1.12Gewoon aandeelEURONEXT - EURONEXT AMSTERDAMISIN NL0010391025AFM:MAR19:20230810FBAF09C5-6A3B-EE11-A305-005056BB4E9F
  • ●
    Chief Commercial OfficerExecutivesAFM delayPharming Group N.V.
    0AFM-MAR19
    247,738 sharesGewoon aandeelOTCISIN NL0010391025AFM:MAR19:202303216E59725F-42C9-ED11-A302-005056BBFEB2
  • ◇
    Chief Commercial OfficerExecutivesAFM delayPharming Group N.V.
    0AFM-MAR19
    138,042 sharesGewoon aandeelOTCISIN NL0010391025AFM:MAR19:20220324322BB1DE-CCB1-EC11-A2F0-005056BBFEB2

7 of 7 declarations